THE VOICE OF ONCOLOGY IN FLORIDA FLASCO is a member supported state society that focuses on providing education, advocacy, communication and general support of the Florida professionals who have chosen the challenging medical discipline of oncology. UPCOMING EVENTS CORPORATE MEMBERSHIP BENEFITS BENEFITS FOR ONCOLOGY PROFESSIONALS FLASCO

Latest News & Updates

FDA Approves VEKLURY (Remdesivir)
October 25, 2020

Continue Reading »

FDA Grants Full Approval For Venclexta In AML
October 22, 2020

Continue Reading »

FDA Approves Opdivo + Yervoy for Previously Untreated Unresectable Malignant Pleural Mesothelioma
October 8, 2020

Continue Reading »

FDA Approves GAVRETO (Pralsetinib) For Adult Patients with Metastatic Rearranged During Transfection Fusion-Positive Non-Small Cell Lung Cancer
October 2, 2020

Continue Reading »

FDA Approves VEKLURY (Remdesivir)
October 25, 2020

Continue Reading »

FDA Grants Full Approval For Venclexta In AML
October 22, 2020

Continue Reading »

FDA Approves Opdivo + Yervoy for Previously Untreated Unresectable Malignant Pleural Mesothelioma
October 8, 2020

Continue Reading »

FDA Approves GAVRETO (Pralsetinib) For Adult Patients with Metastatic Rearranged During Transfection Fusion-Positive Non-Small Cell Lung Cancer
October 2, 2020

Continue Reading »

Get More from FLASCO With Your Membership

The Corporate Membership Program allows FLASCO to expand our offerings to our membership. Every FLASCO meeting also provides the industry representative with opportunities to educate our members. When you send representatives to a FLASCO meeting, you are allowing them to share their knowledge, as well as receive the same knowledge as our members by participating within the educational sessions. This helps ensure that the hematology and oncology community at large are learning, sharing best practices, and finding solutions to problems together.

Corporate Members:

We're Here to Help Contact Us

Contact Us

Add your name, email & message below: